Octreotide: a potent new non-opiate analgesic for intrathecal infusion.
about
Oral morphine for cancer painOral morphine for cancer painOral morphine for cancer painSome of the challenges in drug development for irritable bowel syndromeEffects of octreotide on responses to colorectal distension in the ratNovel Drug Delivery Systems.The epidural and intrathecal administration of somatotrophin-release inhibiting factor: native and synthetic analogues.Review article: palliative care in gynecologic oncology.Treatment of resistant pain in hypertrophic pulmonary osteoarthropathy with subcutaneous octreotide.A review of intrathecal morphine therapy related granulomas.Somatostatin modulates mast cell-induced responses in murine spinal neurons and satellite cells.δ-opioid receptor and somatostatin receptor-4 heterodimerization: possible implications in modulation of pain associated signaling.Effects of somatostatin on the responses of rostrally projecting spinal dorsal horn neurons to noxious stimuli in cats.Somatostatin and somatostatin receptors: implications for neoplastic growth and cancer biology.Somatostatin and its 2A receptor in dorsal root ganglia and dorsal horn of mouse and human: expression, trafficking and possible role in pain.Anticonvulsant neuropeptides as drug leads for neurological diseases.Polyanalgesic consensus conference 2007: recommendations for the management of pain by intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel.The Use of Continuous Intrathecal Infusion of Octreotide in Patients with Chronic Pain of Noncancer Origin: An Evaluation of Side-effects and Toxicity in a Prospective Double-blind Fashion.A history of intraspinal analgesia, a small and personal journey.Pharmacological Management of Cancer-Related Pain.Hypertrophic osteoarthropathy in Eisenmenger syndrome.The use of continuous intrathecal infusion of octreotide in patients with chronic pain of noncancer origin: an evaluation of efficacy in a prospective double-blind fashion.Octreotide as an agent for the relief of malignant ascites in palliative care patients.Octreotide in refractory functional epigastric pain with nutritional impairment--an open study.Immunocytochemical localization of somatostatin receptor sst2A in the rat spinal cord and dorsal root ganglia.Spinal antinociception: clinical aspects.Future trends in the development of local drug delivery systems: intraspinal, intracerebral, and intraparenchymal therapies.Commentary: octreotide and hypertrophic pulmonary osteoarthropathy.The somatostatin analogue octreotide inhibits capsaicin-mediated activation of nociceptive primary afferent fibres in spinal cord lamina II (substantia gelatinosa).Alternative intrathecal agents for the treatment of pain.The Somatostatin Receptor-4 Agonist J-2156 Alleviates Mechanical Hypersensitivity in a Rat Model of Breast Cancer Induced Bone Pain.
P2860
Q24185873-BAD3508A-61DE-482D-B2F9-D96E656064CBQ24201079-4482F39E-C5CC-445F-9586-2957FB68F01FQ24243158-711EF72C-6646-4094-8D31-79DF6ACBBF8CQ28362604-2FB1ADB5-7646-4010-A330-FA0FB09A1F04Q28362629-51EAAF75-F87E-4909-9068-11A94790B0EAQ34040441-357A9D80-C40C-4751-852A-4E3D4A48E1BAQ34040492-A3F2EF4D-C60F-4050-BF50-48B320950F84Q34156710-CF21E4C1-0887-415E-8664-15B14D758481Q35563423-C42F1F26-66ED-437B-AF20-6FC2CE4663F2Q36167357-B389F941-FD94-4D32-B305-A44295B94528Q37297955-B29A8498-49FE-4ACC-84D9-0783B2E055F2Q37453223-52022D99-252A-4632-88D5-D4CCB3F1FEF5Q37459060-60F68304-41DA-40FE-B9B9-2A5788254C84Q37579225-3A3E96A2-0AE7-4FD2-A941-865B44275AECQ37619163-3C74A6CF-531C-4902-AD76-74E234993353Q37845684-BC0184B0-75F1-4EBF-B9A6-2053F996C40EQ37965868-25954F7D-9CC4-4B37-A928-7EFD50B8ED87Q37965951-E3A5FE6E-A01C-44F3-9BFB-F6D70836FAB1Q37996441-F0211907-2959-40D5-81CF-5B84C1471BA3Q38672359-6E8056CC-AC70-4686-913E-8196CB4E1B7AQ39252358-6105FF44-51DB-422E-A771-7E86A1CABF66Q39345495-73D77383-5702-48D5-BD60-26C11FFA57ACQ39433044-B03D3FAD-6ADA-48FB-B68A-7F3EAA1F50D9Q39438200-65531D9D-9DD4-460C-9E9E-C681C55BAC7BQ39442481-6839B69A-C58C-4464-8404-D771BEB92EEBQ40458760-E788373A-CB4A-4B5F-A299-4018A5BC0608Q40819496-208364F3-B4E3-4FF1-BFDD-E6E529C073B0Q43043742-D64F1D39-60CC-473B-952B-2A9BC1714476Q45346514-9D5D0EA6-3070-4CEA-814B-E4C663715F77Q51468178-55EE7FA9-C9AA-49F2-B494-3840C9E640FDQ54977077-255B3547-4859-40ED-B1FA-BE8B5126EE65
P2860
Octreotide: a potent new non-opiate analgesic for intrathecal infusion.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
Octreotide: a potent new non-opiate analgesic for intrathecal infusion.
@en
Octreotide: a potent new non-opiate analgesic for intrathecal infusion.
@nl
type
label
Octreotide: a potent new non-opiate analgesic for intrathecal infusion.
@en
Octreotide: a potent new non-opiate analgesic for intrathecal infusion.
@nl
prefLabel
Octreotide: a potent new non-opiate analgesic for intrathecal infusion.
@en
Octreotide: a potent new non-opiate analgesic for intrathecal infusion.
@nl
P2093
P1433
P1476
Octreotide: a potent new non-opiate analgesic for intrathecal infusion.
@en
P2093
P356
10.1016/0304-3959(92)90182-B
P407
P577
1992-04-01T00:00:00Z